EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 97 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $209,000 | -22.6% | 31,322 | -1.3% | 0.00% | – |
Q2 2021 | $270,000 | -2.9% | 31,734 | +0.9% | 0.00% | – |
Q1 2021 | $278,000 | -35.6% | 31,462 | -10.6% | 0.00% | – |
Q4 2020 | $432,000 | +49.5% | 35,191 | -1.0% | 0.00% | – |
Q3 2020 | $289,000 | – | 35,545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |